02294nas a2200217 4500000000100000008004100001653009800042100001400140700001500154700001300169700001400182700001300196700001200209700001200221700001600233245013900249300001200388490000700400520165500407022001402062 2015 d10aBlindness; Chlamydia trachomatis; elimination program; mathematical modeling; ocular sequelae1 aGambhir M1 aGrassly NC1 aBurton M1 aSolomon A1 aTaylor H1 aMabey D1 aBlake I1 aBasáñez M00aEstimating the future impact of a multi-pronged intervention strategy on ocular disease sequelae caused by trachoma: A modeling study. a394-4020 v223 a
PURPOSE: Trachoma control programs are underway in endemic regions worldwide. They are based on the SAFE strategy (Surgery for trichiasis, Antibiotic distribution, Facial cleanliness, and Environmental improvement). Although much is known about the effect of community-wide treatment with antibiotics on the prevalence of Chlamydia trachomatis, the impact of the SAFE strategy on severe ocular disease sequelae (the main focus of the Global Elimination of blinding Trachoma by 2020 program) remains largely unknown.
METHODS: We use a mathematical model to explore the impact of each of the components of the SAFE strategy, individually and together, on disease sequelae, arising from repeat infection and subsequent conjunctival scarring. We ask whether two elimination goals, to reduce the prevalence of trachomatous trichiasis to 1 per 1000 persons, and the incidence of corneal opacity to 1 per 10,000 persons per annum, are achievable, and which combinations of interventions have the greatest impact on these indicators.
RESULTS: In high prevalence communities (here, >20% infection of children aged 1-9 years), a combination of efforts is needed to bring down sustainably the prevalence and incidence of ocular disease sequelae.
CONCLUSION: The mass delivery of antibiotics is highly beneficial for the clearance of infection, inflammation and prevention of subsequent scarring, but needs to be supplemented with sustained reductions in transmission and surgery to consider realistically the elimination of blindness by the year 2020.
a1744-5086